Leyva Fernando J, Loughin Catherine A, Dewey Curtis W, Marino Dominic J, Akerman Meredith, Lesser Martin L
Department of Surgery, Long Island Veterinary Specialists, Plainview, NY, 11803, USA.
Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA.
BMC Res Notes. 2018 Feb 13;11(1):122. doi: 10.1186/s13104-018-3220-1.
To investigate the histopathologic characteristics of concurrent splenic and liver masses in dogs undergoing splenectomy and liver mass biopsy/resection. Medical records of 125 client-owned dogs found to have splenic mass or masses and a liver mass or masses during surgery were examined. Signalment (age, sex, breed), body weight, and results of histopathology were recorded for all dogs.
Twenty-seven percent (34/125) of the dogs in this study had no evidence of malignancy in either the liver or the spleen. Sixty of 125 dogs (48.0%) had malignancy in the spleen and liver, and 56 (56/60, 93.3%) of those dogs had the same malignancy in both organs. Signalment was similar to that in other reports of splenic pathology. In this clinical population of dogs, 27% of dogs with concurrent gross splenic and liver masses discovered intraoperatively had benign lesions in both locations and therefore had a favorable prognosis.
研究接受脾切除术及肝脏肿物活检/切除术的犬同时出现的脾脏和肝脏肿物的组织病理学特征。检查了125只接受手术时发现有脾脏肿物和肝脏肿物的宠物犬的病历。记录了所有犬的特征(年龄、性别、品种)、体重及组织病理学结果。
本研究中27%(34/125)的犬在肝脏和脾脏均无恶性病变证据。125只犬中有60只(48.0%)在脾脏和肝脏有恶性病变,其中56只(56/60,93.3%)犬在两个器官的恶性病变相同。特征与其他脾脏病理学报告相似。在这一临床犬群中,术中发现同时有明显脾脏和肝脏肿物的犬中有27%在两个部位均为良性病变,因此预后良好。